Literature DB >> 17622115

Ketoprofen poly(lactide-co-glycolide) physical interaction.

Paolo Blasi1, Aurélie Schoubben, Stefano Giovagnoli, Luana Perioli, Maurizio Ricci, Carlo Rossi.   

Abstract

The aim of this work was to provide an understanding of the interaction occurring between ketoprofen and poly(lactic-co-glycolic acid) (PLGA) that leads to polymer plasticization. Experimental glass transition temperature (Tg) values were fitted with the theoretical ones predicted by the Fox and Gordon-Taylor/Kelley-Bueche equations. PLGA films containing different amounts of ketoprofen (KET) were prepared by solvent casting and characterized by scanning electron microscopy, differential scanning calorimetry, and Fourier transform infrared spectroscopy (FTIR). Differential scanning calorimetry evidenced that KET acted as a plasticizer in a similar biphasic way in both end-capped and uncapped PLGA. At KET contents of 20% to 35%, depending on the investigated polymer, the Tg was around 23 degrees C. Higher KET amounts did not lower further the Tg, and the excess of drug was found to crystallize into the polymeric matrix. Experimental Tg's deviated negatively from the predicted ones probably because of hydrogen bonding. The FTIR spectra of the films, loaded with different amounts of KET, showed a shift to higher wavenumbers for the peaks at 1697 and 1655 cm(-1) confirming the presence of some interactions, probably hydrogen bonds between the ketoprofen carboxylic group and the PLGA carbonyl groups along the polymer backbone. The hydrogen bonding between KET and PLGA is probably responsible for KET plasticizing effect. KET behaving as a lubricant may disrupt polymer chain-chain interactions, removing additional barriers to bond rotation and chain mobility.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17622115      PMCID: PMC2750376          DOI: 10.1208/pt0802037

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  18 in total

1.  Conformational study of ketoprofen by combined DFT calculations and Raman spectroscopy.

Authors:  M L Vueba; M E Pina; F Veiga; J J Sousa; L A E Batista de Carvalho
Journal:  Int J Pharm       Date:  2005-11-04       Impact factor: 5.875

2.  Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization.

Authors:  T Matsumoto; G Zografi
Journal:  Pharm Res       Date:  1999-11       Impact factor: 4.200

3.  Biodegradable microspheres as carriers for native superoxide dismutase and catalase delivery.

Authors:  Stefano Giovagnoli; Paolo Blasi; Maurizio Ricci; Carlo Rossi
Journal:  AAPS PharmSciTech       Date:  2004-10-11       Impact factor: 3.246

4.  Predicting plasticization efficiency from three-dimensional molecular structure of a polymer plasticizer.

Authors:  M Tarvainen; R Sutinen; M Somppi; P Paronen; A Poso
Journal:  Pharm Res       Date:  2001-12       Impact factor: 4.200

5.  Formation of physically stable amorphous drugs by milling with Neusilin.

Authors:  Manish K Gupta; Adam Vanwert; Robin H Bogner
Journal:  J Pharm Sci       Date:  2003-03       Impact factor: 3.534

6.  Leucinostatin-A loaded nanospheres: characterization and in vivo toxicity and efficacy evaluation.

Authors:  Maurizio Ricci; Paolo Blasi; Stefano Giovagnoli; Luana Perioli; Claudia Vescovi; Carlo Rossi
Journal:  Int J Pharm       Date:  2004-05-04       Impact factor: 5.875

7.  Non-traditional plasticization of polymeric films.

Authors:  C Wu; J W McGinity
Journal:  Int J Pharm       Date:  1999-01-15       Impact factor: 5.875

8.  Preparation of three-month depot injectable microspheres of leuprorelin acetate using biodegradable polymers.

Authors:  H Okada; Y Doken; Y Ogawa; H Toguchi
Journal:  Pharm Res       Date:  1994-08       Impact factor: 4.200

9.  Biodegradable ibuprofen-loaded PLGA microspheres for intraarticular administration. Effect of Labrafil addition on release in vitro.

Authors:  A Fernández-Carballido; R Herrero-Vanrell; I T Molina-Martínez; P Pastoriza
Journal:  Int J Pharm       Date:  2004-07-26       Impact factor: 5.875

10.  Solid state NMR perspective of drug-polymer solid solutions: a model system based on poly(ethylene oxide).

Authors:  Deborah M Schachter; Jincheng Xiong; Gloria C Tirol
Journal:  Int J Pharm       Date:  2004-08-20       Impact factor: 5.875

View more
  5 in total

1.  Anti-Toxoplasma activity and impact evaluation of lyophilization, hot molding process, and gamma-irradiation techniques on CLH-PLGA intravitreal implants.

Authors:  Gabriella M Fernandes-Cunha; Cíntia M F Rezende; Wagner N Mussel; Gisele R da Silva; Elionai C de L Gomes; Maria I Yoshida; Sílvia L Fialho; Alfredo M Goes; Dawison A Gomes; Ricardo W de Almeida Vitor; Armando Silva-Cunha
Journal:  J Mater Sci Mater Med       Date:  2015-12-16       Impact factor: 3.896

2.  Tunable Release of Multiclass Anti-HIV Drugs that are Water-Soluble and Loaded at High Drug Content in Polyester Blended Electrospun Fibers.

Authors:  Daniel Carson; Yonghou Jiang; Kim A Woodrow
Journal:  Pharm Res       Date:  2015-08-19       Impact factor: 4.200

3.  Bioactive long-term release from biodegradable microspheres preserves implanted ALG-PLO-ALG microcapsules from in vivo response to purified alginate.

Authors:  Stefano Giovagnoli; Paolo Blasi; Giovanni Luca; Francesca Fallarino; Mario Calvitti; Francesca Mancuso; Maurizio Ricci; Giuseppe Basta; Ennio Becchetti; Carlo Rossi; Riccardo Calafiore
Journal:  Pharm Res       Date:  2009-12-31       Impact factor: 4.200

4.  Anisotropic microparticles for differential drug release in nerve block anesthesia.

Authors:  Shivakumar B S; Vignesh Gopalakrishnan-Prema; Gayathri Raju; Sumi E Mathew; Neeraj Katiyar; Deepthy Menon; Sahadev A Shankarappa
Journal:  RSC Adv       Date:  2021-01-22       Impact factor: 3.361

5.  How bulk fluid renewal can affect in vitro drug release from PLGA implants: Importance of the experimental set-up.

Authors:  C Bassand; L Benabed; J Freitag; J Verin; F Siepmann; J Siepmann
Journal:  Int J Pharm X       Date:  2022-09-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.